Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
4.590
+0.100 (2.23%)
At close: Aug 14, 2026, 4:00 PM EDT
4.570
-0.020 (-0.44%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Emergent BioSolutions Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
139.7205.499.5111.7642.6576.1
Trading Asset Securities
----8.5-
Cash & Short-Term Investments
139.7205.499.5111.7651.1576.1
Cash Growth
-47.74%106.43%-10.92%-82.84%13.02%-7.27%
Accounts Receivable
19084.2154.5191159.2278.9
Receivables
19084.2154.5191159.2278.9
Inventory
303.6343.4311.7328.9350.7344.5
Prepaid Expenses
25.425.826.947.949.468.2
Restricted Cash
1.23.76.1--0.2
Other Current Assets
6.1----2
Total Current Assets
666662.5598.7679.51,2101,270
Property, Plant & Equipment
183.8216282.3399837828.4
Goodwill
----218.2224.9
Other Intangible Assets
261.8436.5501.5566.6728.8604.6
Long-Term Deferred Charges
-----1.6
Other Long-Term Assets
5.23.67.2178.1171.928.3
Total Assets
1,1171,3191,3901,8233,1662,958

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
50.255.660.9112.2103.5128.9
Accrued Expenses
43.35473.892.7122.2140.4
Current Portion of Long-Term Debt
---413.7957.336.1
Current Portion of Leases
1.52.42.73.55.85.8
Current Income Taxes Payable
4.46.85.8---
Current Unearned Revenue
1554.827.226.411.7
Other Current Liabilities
8.48.414.4213.751.1
Total Current Liabilities
122.8132.2162.4651.31,229374
Long-Term Debt
581.8572.1663.7446.5448.5811
Long-Term Leases
4.99.29.713.814.824.2
Long-Term Deferred Tax Liabilities
35.437.841.747.259.793.3
Other Long-Term Liabilities
30.544.729.415.126.743.7
Total Liabilities
775.4796906.91,1741,7791,346

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Additional Paid-In Capital
951.8942.4928904.4873.5829.4
Retained Earnings
-333.2-159.8-212.4-21.8738.7950.3
Treasury Stock
-270.5-252.6-227.7-227.7-227.7-152.2
Comprehensive Income & Other
-6.8-7.5-5.2-5.73.1-16.1
Shareholders' Equity
341.4522.6482.8649.31,3881,612
Total Liabilities & Equity
1,1171,3191,3901,8233,1662,958

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
588.2583.7676.1877.51,426877.1
Net Cash (Debt)
-448.5-378.3-576.6-765.8-775.3-301
Net Cash Growth
------
Net Cash Per Share
-8.59-6.67-10.88-14.96-15.48-5.56
Filing Date Shares Outstanding
51.2751.7754.3452.250.1450.5
Total Common Shares Outstanding
51.352.1354.3352.250.151.3
Working Capital
543.2530.3436.328.2-18.5895.9
Book Value Per Share
6.6510.028.8912.4427.7031.41
Tangible Book Value
79.686.1-18.782.7440.7782
Tangible Book Value Per Share
1.551.65-0.341.588.8015.24
Land
16.520.725.83054.952.1
Buildings
140.3160.5196.1229.9327.9269.7
Machinery
249.6259.8368.3433.6567.5513.5
Construction In Progress
6.76.610.336.7185.5223.2
SEC Filings: 10-K · 10-Q